NEWS & EVENTS

Press Releases

Boston Pharmaceuticals to Present at 2018 BIO CEO & Investor Conference

2/6/2018

1/4/2018

Pierre Fabre Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Selective Potassium Channel Blocker for Atrial Fibrillation

1/3/2018

Boston Pharmaceuticals Appoints Dr. Peter Ho as Chief Medical Officer

8/28/2017

Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors

Upcoming Events

18th Annual Biotech in Europe Forum October 4-5, Basel, Switzerland

18th Annual Biotech in Europe Forum
October 4-5, Basel, Switzerland

BioNetwok Partnering Summit October 10-12, Laguna Niguel, CA

BioNetwok Partnering Summit
October 10-12, Laguna Niguel, CA